Prime Medicine (PRME) Tax Provisions (2021 - 2024)
Prime Medicine's (PRME) quarterly Tax Provisions came in at -$134000.0 in Q2 2024, down 532.26% YoY from $31000.0 in Q3 2023, and down 200.0% on a QoQ basis from $134000.0 in Q1 2024.
Prime Medicine (PRME) Tax Provisions (2021 - 2024) Analysis & Trends
Prime Medicine (PRME) has 4 years of Tax Provisions data on file, last reported at -$134000.0 in Q2 2024.
- Quarterly Tax Provisions fell 532.26% year-over-year to -$134000.0 in Q2 2024, while the trailing twelve-month figure through Mar 2025 was -$134000.0 (down 335.09% YoY) and the FY2023 annual result came in at -$279000.0, up 70.57% from the prior year.
- Tax Provisions slipped to -$134000.0 in Q2 2024, from $134000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $1.4 million in Q4 2021 to a low of -$2.4 million in Q3 2021.
- A 4-year average of -$201454.5 and a median of -$134000.0 in 2024 frame the typical range for Tax Provisions.
- The widest YoY moves for Tax Provisions: up 166.34% in 2024, down 532.26% in 2024.
- Tracing PRME's Tax Provisions over 4 years: stood at $1.4 million in 2021, then plunged by 113.47% to -$186000.0 in 2022, then jumped by 41.94% to -$108000.0 in 2023, then decreased by 24.07% to -$134000.0 in 2024.
- The last three Tax Provisions figures came in at -$134000.0 (Q2 2024), $134000.0 (Q1 2024), and -$108000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Prime Medicine | 558.48 Mn | 558.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -134,000.00 |
| Mar 31, 2024 | 134,000.00 |
| Sep 30, 2023 | -108,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | -202,000.00 |
| Dec 31, 2022 | -186,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | -442,000.00 |
| Mar 31, 2022 | -532,000.00 |
| Dec 31, 2021 | 1.38 Mn |
| Sep 30, 2021 | -2.37 Mn |